Free Trial

Stevanato Group Q3 2024 Earnings Report

Stevanato Group logo
€22.24 -0.61 (-2.67%)
As of 03:58 PM Eastern

Stevanato Group EPS Results

Actual EPS
€0.12
Consensus EPS
€0.13
Beat/Miss
Missed by -€0.01
One Year Ago EPS
€0.16

Stevanato Group Revenue Results

Actual Revenue
$277.90 million
Expected Revenue
$274.36 million
Beat/Miss
Beat by +$3.54 million
YoY Revenue Growth
+2.40%

Stevanato Group Announcement Details

Quarter
Q3 2024
Time
Before Market Opens

Stevanato Group Earnings Headlines

Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
See More Stevanato Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stevanato Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stevanato Group and other key companies, straight to your email.

About Stevanato Group

Stevanato Group (NYSE:STVN) engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

View Stevanato Group Profile

More Earnings Resources from MarketBeat